$CBRSBearishLow

The Cerebras IPO Just Showed Us Exactly What’s Coming With SpaceX

The article argues that AI IPOs may follow a “lockup trap” structure that enables early insider selling. It cites Figma’s IPO: priced at $33, opened at $115, and a performance-based lockup release triggered on Day 1; insiders sold at about $80 within 36 days and the stock later fell to $22. It says Cerebras priced at $185 and opened at $350, and claims SpaceX, Anthropic, and OpenAI may use similar setups.

7/10
3/10
Low
Bearish
post-IPO day setup; before the next AI IPO wave
Contrarian/defensive versus IPO FOMO

IPO pop is portrayed as potential exit-liquidity for insiders rather than durable upside.

Article frames Cerebras’ IPO pricing/opening and argues the lockup structure can drive early insider selling and post-IPO downside.

Near-term downside risk around lockup/early-release mechanics; elevated volatility expected post-listing.

Background

Uses Figma’s IPO lockup performance-trigger and subsequent insider selling as a template to interpret the current AI IPO boom.

Why it matters

Suggests traders should expect selling pressure and volatility around IPO/lockup windows, and prefer liquid “proxy” names over buying the IPO open.

Market relevance

Material mainly for CBRS as the article’s subject; broader relevance is a contrarian framework for AI IPO trading risk.

Market effects

Could reinforce a broader risk-off trade around AI IPOs where underpricing and early lockup releases may concentrate selling pressure.

No specific regional catalyst; applies to US-listed IPOs.

Read-across to global AI IPO pipeline structuring by banks/underwriters.

Alternative perspectives

Even if lockup mechanics exist, strong fundamentals or demand could overwhelm early selling, making the IPO pop sustainable.

The article is largely an opinion/structure thesis and does not provide Cerebras-specific lockup trigger details or confirmed insider sale timing beyond the general Figma analogy.

Key entities

  • Cerebras Systems

    Subject of the article’s IPO discussion (priced at $185, opened at $350, down 10% next day).

  • Figma

    Used as the blueprint example for performance-triggered early lockup release and insider selling.

  • Marc Chaikin

    Referenced for tools/indicators used to identify institutional flows and “convergence” setups.

Related articles

$CBRSMed

Cerebras shares jump as Wall Street initiates coverage with bullish calls

Cerebras Systems (NASDAQ:CBRS) shares rose about 23% after the post–quiet period coverage began for the AI chip designer. At least nine brokerages initiated, with price targets ranging from $250 (Morgan Stanley) to $300 (Mizuho/UBS/Rosenblatt) and $270 (Wedbush). UBS cited fast inference demand, OpenAI pre-payment shipments, and AWS collaborations, setting a $300 target based on 10x EV/Sales of 2029E $11.2B revenue.

$SNDKMedAI 8/10

These 2 AI Stocks Dominated Headlines in May. How to Play Them in June.

In May, Wall Street rated SanDisk “Strong Buy” overall, with 18 of 22 analysts bullish; one “Moderate Buy” and three “Hold.” The stock has surpassed its mean target, while the Street-high estimate is $3,250 (about 82% upside). Cerebras’ IPO shares rose ~68% on May 14 to $311.07, then fell 24%; market cap is ~$47B. Cerebras reported revenue up 76% YoY to $510M and net income of $237.8M in 2025.

$CRWVLow

3 AI Stocks Born From Recent IPOs That Could Be Bigger Than Their Hype

The article highlights three AI-focused public companies from recent listings: CoreWeave (CRWV), Cerebras (CBRS), and Nebius Group (NBIS). CoreWeave IPO’d March 28, 2025 at $40; it reported Q1 2026 revenue of $2.1B (+112% YoY) and forecasts $12B–$13B for 2026, with $99.4B backlog, but carries $35.1B debt. Cerebras debuted May 14, 2025 at $185; 2025 revenue was $510M (+76% YoY) and it trades at ~100x trailing sales. Nebius Group reported Q1 2026 revenue of $399M (+684% YoY) and guided $3.0B–$3.4B

$NVDALow

Better AI Inference Stock to Own: Nvidia or Cerebras?

The article argues that AI inference may become a larger market than LLM training and compares Nvidia (NVDA) with Cerebras (CBRS). It says Nvidia’s $20 billion “acquisition” of Groq gives it inference-focused LPUs integrated into CUDA and rack systems with GPUs using HBM for prefill and LPUs for decode. It says Cerebras uses wafer-scale SRAM chips sold as CS-3 systems, claiming 15x faster inference but facing yield, cooling, and high valuation concerns.

$CBRSMedAI 9/10

Cerebras Is Down 22% Since Its IPO Popped. Should You Buy It Now?

Cerebras (CBRS) surged 68% on its IPO day but shares have fallen more than 22% since the May 14 close. The company’s wafer-scale AI chips are designed to reduce memory-to-compute bottlenecks, and it says its Kimi K2.6 trillion-parameter model runs 6.7x faster on a ~20-system cluster. OpenAI signed a $20B deal (up to 750 MW through 2028) and Cerebras had $24.6B in remaining performance obligations; it expects ~15% to be recognized in 24 months.